全球药物数据库

全球药物数据库是一个综合性的数据库，旨在收录全球已上市和未上市的所有药物，更侧重于新药信息。数据库展现了药物的摘要信息、基本信息、中国注册申报情况、各国上市情况、全球市场销售情况、药品标准、说明书、中标信息、临床试验情况、专利布局等。全球药物分析系统立足新药研发，围绕创新药，改良型新药，生物类似药，从靶点，适应症，企业多维度分析，展现了药物的全方位信息（包括基础信息、研发状态、原研单位及药品概述等），为企业进行药物研发和市场调研提供最优质完整的数据。数据来源：各国药监机构：FDA，EMA，HMA，，NMPA，PMDA；中国，美国，WHO临床登记平台；企业官网管线；医药新闻PR站点：路透社，美通社等

The Global Drug Database is a comprehensive database designed to collect all drugs, both marketed and unmarketed, across the globe, with a particular emphasis on new drug-related information. The database provides access to a wide range of drug-related details, including summary information, basic information, China's registration and declaration status, marketing status in various countries, global market sales data, drug standards, package inserts, winning bid information, clinical trial status, and patent portfolios, among others.

The Global Drug Analysis System focuses on new drug R&D, conducting multi-dimensional analyses from the perspectives of targets, indications and enterprises, covering innovative drugs, improved new drugs and biosimilars. It presents comprehensive drug information including basic information, R&D status, originator enterprises and drug overviews, etc. The system provides high-quality and comprehensive data to support enterprises in carrying out drug R&D and market research.

Data sources: National drug regulatory authorities including FDA, EMA, HMA, NMPA and PMDA; clinical trial registration platforms of China, the United States and the World Health Organization (WHO); drug pipeline information from enterprise official websites; and medical PR news outlets such as Reuters and PR Newswire, etc.

搜集汇总

背景与挑战

背景概述

该数据库全面收录全球已上市和研发中的药物信息，特别聚焦新药研发动态，提供从靶点分析到市场销售的多维度数据。数据源自各国药监机构、临床试验平台及企业官方渠道，支持药物研发与市场决策。